Neuberger Berman Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320M Buy
3,698,203
+123,155
+3% +$11.8M 0.24% 73
2025
Q4
$343M Buy
3,575,048
+93,297
+3% +$9.06M 0.26% 71
2025
Q3
$331M Sell
3,481,751
-170,875
-5% -$15.7M 0.24% 81
2025
Q2
$318M Sell
3,652,626
-827,343
-18% -$70.2M 0.24% 84
2025
Q1
$403M Buy
4,479,969
+227,853
+5% +$20.4M 0.34% 60
2024
Q4
$340M Buy
4,252,116
+2,454,223
+137% +$212M 0.27% 81
2024
Q3
$162M Buy
1,797,893
+1,139,799
+173% +$95.9M 0.13% 204
2024
Q2
$51.8M Buy
658,094
+242,466
+58% +$19.9M 0.04% 413
2024
Q1
$36.2M Buy
415,628
+71,181
+21% +$6.07M 0.03% 516
2023
Q4
$28.4M Sell
344,447
-3,366,150
-91% -$257M 0.02% 533
2023
Q3
$291M Buy
3,710,597
+17,482
+0.5% +$1.46M 0.27% 90
2023
Q2
$325M Buy
3,693,115
+1,611,028
+77% +$139M 0.29% 81
2023
Q1
$168M Buy
2,082,087
+1,716,724
+470% +$140M 0.16% 175
2022
Q4
$28.4M Sell
365,363
-2,232,348
-86% -$181M 0.03% 540
2022
Q3
$210M Sell
2,597,711
-2,857,154
-52% -$257M 0.22% 126
2022
Q2
$490M Buy
5,454,865
+794,444
+17% +$80.5M 0.49% 28
2022
Q1
$517M Buy
4,660,421
+221,183
+5% +$23.4M 0.44% 35
2021
Q4
$458M Sell
4,439,238
-529,049
-11% -$61.3M 0.36% 55
2021
Q3
$621M Buy
4,968,287
+956,360
+24% +$124M 0.54% 17
2021
Q2
$497M Buy
4,011,927
+28,779
+0.7% +$3.61M 0.43% 37
2021
Q1
$470M Buy
3,983,148
+574,737
+17% +$67.4M 0.45% 30
2020
Q4
$399M Buy
3,408,411
+305,945
+10% +$33.7M 0.41% 41
2020
Q3
$322M Sell
3,102,466
-974,265
-24% -$97.8M 0.38% 57
2020
Q2
$374M Buy
4,076,731
+63,583
+2% +$6.1M 0.46% 35
2020
Q1
$362M Buy
4,013,148
+453,609
+13% +$48.3M 0.55% 25
2019
Q4
$404M Sell
3,559,539
-3,014
-0.1% -$331K 0.47% 29
2019
Q3
$387M Sell
3,562,553
-243,538
-6% -$25.4M 0.47% 31
2019
Q2
$371M Buy
3,806,091
+1,025,084
+37% +$93.6M 0.44% 41
2019
Q1
$253M Buy
2,781,007
+856,859
+45% +$76.7M 0.31% 72
2018
Q4
$175M Sell
1,924,148
-104,871
-5% -$9.8M 0.24% 111
2018
Q3
$200M Sell
2,029,019
-8,327
-0.4% -$770K 0.23% 129
2018
Q2
$174M Buy
2,037,346
+110,839
+6% +$9.26M 0.19% 157
2018
Q1
$154M Buy
1,926,507
+226,988
+13% +$18.7M 0.18% 177
2017
Q4
$137M Sell
1,699,519
-138,214
-8% -$11.1M 0.16% 204
2017
Q3
$143M Sell
1,837,733
-19,484
-1% -$1.62M 0.18% 182
2017
Q2
$165M Sell
1,857,217
-35,765
-2% -$3.02M 0.21% 151
2017
Q1
$152M Sell
1,892,982
-78,171
-4% -$6.11M 0.2% 163
2016
Q4
$140M Sell
1,971,153
-31,685
-2% -$2.49M 0.19% 176
2016
Q3
$173M Buy
2,002,838
+117,402
+6% +$10.2M 0.23% 123
2016
Q2
$164M Buy
1,885,436
+46,821
+3% +$3.79M 0.23% 128
2016
Q1
$138M Buy
1,838,615
+1,694,906
+1,179% +$128M 0.19% 162
2015
Q4
$11.1M Sell
143,709
-883
-0.6% -$66.5K 0.01% 747
2015
Q3
$9.68M Sell
144,592
-11,698
-7% -$862K 0.01% 792
2015
Q2
$11.6M Sell
156,290
-136,229
-47% -$10.4M 0.01% 802
2015
Q1
$22.8M Buy
292,519
+27,558
+10% +$2.09M 0.02% 657
2014
Q4
$19.1M Buy
264,961
+2,327
+0.9% +$162K 0.02% 677
2014
Q3
$16.3M Sell
262,634
-45,399
-15% -$2.89M 0.02% 732
2014
Q2
$19.6M Sell
308,033
-547,688
-64% -$33.3M 0.02% 666
2014
Q1
$52.7M Sell
855,721
-853
-0.1% -$49.7K 0.05% 420
2013
Q4
$49.2M Sell
856,574
-65,439
-7% -$3.71M 0.05% 430
2013
Q3
$49.1M Sell
922,013
-11,650
-1% -$627K 0.05% 415
2013
Q2
$48.1M Buy
+933,663
New +$46.2M 0.06% 406

Other funds holding MDT

Neuberger Berman Group's MDT Position: Q1 2026 in Review

Neuberger Berman Group increased its Medtronic (MDT) stake by 3.4% in Q1 2026, buying an estimated $11.8M and bringing the position to 3,698,203 shares worth $320M. The position accounts for 0.24% of the portfolio, ranked #73.

Neuberger Berman Group first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $621M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Neuberger Berman Group held 3,698,203 shares of Medtronic worth $320M as of Q1 2026.
  • Neuberger Berman Group bought 123,155 Medtronic shares in Q1 2026, an estimated $11.8M.
  • Medtronic made up 0.24% of Neuberger Berman Group's portfolio in Q1 2026, its #73 holding.
  • Neuberger Berman Group first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Medtronic position peaked at $621M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.